MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 70 filers reported holding MONTE ROSA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,839,311 | -30.3% | 592,758 | -0.4% | 0.00% | – |
| Q2 2023 | $4,075,990 | -1.4% | 595,035 | +12.1% | 0.00% | – |
| Q1 2023 | $4,134,511 | -47.5% | 530,746 | -48.7% | 0.00% | – |
| Q4 2022 | $7,874,462 | +98.9% | 1,034,752 | +113.5% | 0.00% | – |
| Q3 2022 | $3,959,000 | -9.2% | 484,571 | +7.5% | 0.00% | – |
| Q2 2022 | $4,360,000 | -15.8% | 450,864 | +22.0% | 0.00% | – |
| Q1 2022 | $5,181,000 | +27.1% | 369,568 | +85.2% | 0.00% | – |
| Q4 2021 | $4,075,000 | +20.7% | 199,576 | +31.7% | 0.00% | – |
| Q3 2021 | $3,376,000 | – | 151,542 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $7,052,465 | 2.91% |
| NEA Management Company, LLC | 7,692,298 | $36,846,107 | 2.85% |
| Octagon Capital Advisors LP | 812,895 | $3,893,767 | 0.60% |
| Alphabet Inc. | 1,464,015 | $7,012,631 | 0.45% |
| Avoro Capital Advisors LLC | 4,535,000 | $21,722,650 | 0.34% |
| Casdin Capital, LLC | 510,882 | $2,447,125 | 0.27% |
| Baker Brothers Advisors | 4,916,095 | $23,548,095 | 0.14% |
| Corton Capital Inc. | 14,460 | $69,263 | 0.04% |
| ExodusPoint Capital Management, LP | 619,248 | $2,966 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 27,844 | $133,373 | 0.02% |